NextCure, Inc.
NXTC • NASDAQ
NextCure, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael S. Richman, with a market cap of $39.9M.
Market Cap$39.9M
Employees82.0
CEOMichael S. Richman
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 30, 2026 · In 2 weeksQ1 2026
Financials
NXT
NextCure, Inc. FAQ
Common questions about NextCure, Inc.
NextCure, Inc. is scheduled to report earnings for Q1 2026 on April 30, 2026.
NextCure, Inc. has approximately 82 employees.